Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Innate Pharma

Innate Pharma
$7.45 SHARE PRICE (As of Thursday Closing)

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results primarily from payments received in relation to research, collaboration and licensing agreements signed with pharmaceutical companies.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Stock Exchange
Primary Office
  • 117, Avenue de Luminy - BP 30191
  • 13009 Marseille
  • France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Innate Pharma’s full profile, request a free trial.

Innate Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$5.80 - $8.43 $585M $7.63 $0.59 332K 78.5M

Innate Pharma Financials Summary

In Thousands,
FY 2018
FY 2017
FY 2016
Enterprise Value 219,011 437,620 134,861 609,846
Revenue 131,490 94,278 36,800 62,121
EBITDA 49,183 12,061 (49,069) 18,061
Net Income 35,826 3,598 (54,567) 13,982
Total Assets 400,854 516,147 305,952 296,135
Total Debt 5,638 5,173 7,035 5,602
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Innate Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
Debt Status

This information is reserved for PitchBook Platform users. To explore Innate Pharma‘s full profile, request access.

Request full access to PitchBook

Innate Pharma Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000 Venture Capital-Backed Utrecht, Netherlands 00.000 00000000000 00.000
000000 Venture Capital-Backed Lebanon, NH 000 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Innate Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000 (0000 13-Jul-2017 000000000 00000 00 00000 Pharmaceuticals 0000000 00000000 00
Novo Nordisk (anti-NKG2A) 05-Feb-2014 Corporate Asset Purchase Buildings and Property 0000é 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

Innate Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Innate Pharma‘s full profile, request access.

Request full access to PitchBook

Innate Pharma Executive Team (21)

Name Title Board
Mondher Mahjoubi MD Chief Executive Officer & Executive
Laure-Hélène Mercier Chief Financial Officer & Executive Vice President
Jerome Tiollier Ph.D Executive Vice President & Chief Development Officer
Eric Vivier Ph.D Chief Scientific Officer & Executive
Nicolai Wagtmann Ph.D Member of the Executive Board & Chief Scientific Officer

3 Former Executives

You’re viewing 5 of 21 executives. Get the full list »

Innate Pharma Board Members (17)

Name Representing Role Since Contact
Bernard Malissen Self Chairman of Scientific advisory Board 000 0000
David Raulet Ph.D Self Member of Scientific Advisory Board 000 0000
François Romagné Ph.D Innate Pharma Co-Founder & Member of Scientific Board 000 0000
Gilles Brisson Self Board Member 000 0000
Hervé Brailly Ph.D Innate Pharma Co-Founder & Chairman 000 0000

4 Former Board Members

You’re viewing 5 of 17 board members. Get the full list »